Adherence to GOLD Recommendations among Swiss Pulmonologists and General Practitioners

References

• GOLD. 2019 Global Strategy for Prevention, Diagnosis and Management of COPD. Fontana, WI, USA: Global Initiative for Chronic Obstructive Lung Disease, Inc.; 2019 [cited 2019 July 1]. Available from: https://goldcopd.org/gold-reports/
   Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. DOI:10.1016/S0140-6736(07)61377-4
   PubMed Web of Science ®Google Scholar
• Tschopp J, Dumont P, Hayoz D. True prevalence of COPD and its association with peripheral arterial disease in the internal medicine ward of a tertiary care hospital. Swiss Med Wkly. 2017;147:w14460.
   PubMed Web of Science ®Google Scholar
• Sehl J, O'Doherty J, O'Connor R, et al. Adherence to COPD management guidelines in general practice? A review of the literature. Ir J Med Sci. 2018;187(2):403–407. DOI:10.1007/s11845-017-1651-7
   PubMed Web of Science ®Google Scholar
• Foda HD, Brehm A, Goldsteen K, et al. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:209–214. DOI:10.2147/COPD.S119507
   PubMed Web of Science ®Google Scholar
• Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, et al. European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions. Thorax. 2013;68(12):1169–1171. DOI:10.1136/thoraxjnl-2013-203465
   PubMed Web of Science ®Google Scholar
• Grewe FA, Sievi NA, Bradicich M, et al. Compliance of pharmacotherapy with GOLD guidelines: a longitudinal study in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:627–635. DOI:10.2147/COPD.S240444
   PubMed Web of Science ®Google Scholar
• Davis KJ, Landis SH, Oh YM, et al. Continuing to confront COPD international physician survey: physician knowledge and application of COPD management guidelines in 12 countries. Int J Chron Obstruct Pulmon Dis. 2015;10:39–55.
   PubMed Web of Science ®Google Scholar
• Jochmann A, Neubauer F, Miedinger D, et al. General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss Med Wkly. 2010;140:w13053.
   Web of Science ®Google Scholar
• Urwyler P, Abu Hussein N, Bridevaux PO, et al. Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort. Multidiscip Respir Med. 2019;14(1):7. DOI:10.1186/s40248-019-0168-5
   PubMedGoogle Scholar
• Ulrik CS, Hansen EF, Jensen MS, et al. Management of COPD in general practice in Denmark – participating in an educational program substantially improves adherence to guidelines. Int J Chron Obstruct Pulmon Dis. 2010;5:73–79.
   PubMedGoogle Scholar
• Román-Rodríguez M, Pardo MG, López LG, et al. Enhancing the use of Asthma and COPD Assessment Tools in Balearic Primary Care (ACATIB): a region-wide cluster-controlled implementation trial. NPJ Prim Care Respir Med. 2016;26:16003. DOI:10.1038/npjpcrm.2016.3
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Abad Arranz M, Calero Acuña C, et al. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit. Int J Chron Obstruct Pulmon Dis. 2016;11:1171–1178. DOI:10.2147/COPD.S103614
   PubMed Web of Science ®Google Scholar
• Price D, West D, Brusselle G, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis. 2014;9:889–904. DOI:10.2147/COPD.S62750
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. DOI:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J. 2008;15(1):13–19. DOI:10.1155/2008/173904
   PubMed Web of Science ®Google Scholar
• Perez X, Wisnivesky JP, Lurslurchachai L, et al. Barriers to adherence to COPD guidelines among primary care providers. Respir Med. 2012;106(3):374–381. DOI:10.1016/j.rmed.2011.09.010
   PubMed Web of Science ®Google Scholar
• White P, Thornton H, Pinnock H, Georgopoulou S, et al. Overtreatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational study. PLoS One. 2013;8(10):e75221. DOI:10.1371/journal.pone.0075221
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Navarrete BA, Soriano JB, et al. Determinants of medical prescriptions for COPD care: an analysis of the EPOCONSUL clinical audit. Int J Chron Obstruct Pulmon Dis. 2018;13:2279–2288. DOI:10.2147/COPD.S160842
   PubMed Web of Science ®Google Scholar
• Ernst P, Saad N, Suissa S. Inhaled corticosteroids in COPD: the clinical evidence. Eur Respir J. 2015;45(2):525–537. DOI:10.1183/09031936.00128914
   PubMed Web of Science ®Google Scholar
• Kaplan AG. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. Int J Chron Obstruct Pulmon Dis. 2015;10:2535–2548. DOI:10.2147/COPD.S93321
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Cosio BG, Arnedillo A, et al. A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. Respir Res. 2017;18(1):198. DOI:10.1186/s12931-017-0682-y
   PubMed Web of Science ®Google Scholar